Kestra Medical Technologies, Ltd.

Element Science, Inc.HealthtechUnited States

68% matchPrivate

Element Science, Inc. is a U.S. medical-device company developing wearable cardiac-monitoring and defibrillation technologies, including the Jewel Patch wearable cardioverter defibrillator. Its products are intended to serve patients at temporary risk of sudden cardiac death and the clinicians who manage their care.

iRhythm Technologies, Inc. is headquartered in San Francisco, United States, and focuses on the provision of ambulatory ECG monitoring products and digital healthcare solutions for cardiac care.

Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States. The company's efforts are dedicated to supplying remote monitoring capabilities to the medical, healthcare, and individual consumer markets, encompassing both diagnostic tools and ongoing management support for chronic and lifestyle-related conditions. Among its key offerings are the Bioflux mobile cardiac telemetry solution, an integrated ECG device, alongside specialized ECG analysis software designed to process and synthesize patient heart rhythm data, complemented by various software components.

BardyDxMedical DevicesUnited States

65% match

BardyDx (Bardy Diagnostics) is a medical technology company that provides ambulatory electrocardiogram (ECG) monitoring solutions, notably featuring the CAM patch for cardiac rhythm monitoring.

BIOTRONIK SE & Co. KGMedical DevicesGermany

64% match

BIOTRONIK SE & Co. KG designs, manufactures, and provides medical devices and technologies for cardiac rhythm management, vascular intervention, and neuromodulation. The company's product portfolio includes pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) systems, implantable cardiac monitors, and remote patient monitoring solutions. BIOTRONIK serves healthcare professionals, hospitals, and patients by offering solutions for the diagnosis, treatment, and management of heart diseases and chronic pain.

CardioMEMS, Inc. was a U.S. medical-device company that developed wireless, implantable sensors for monitoring pulmonary artery pressure in patients with heart failure. Its technology, including the CardioMEMS HF System, helps clinicians detect worsening heart failure earlier and manage treatment remotely; the company was acquired by Abbott in 2014.